Cargando…
Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan
BACKGROUND: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions. The RBC antigens and their alloantibodies vary among different human populations and ethnic groups, and...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082716/ https://www.ncbi.nlm.nih.gov/pubmed/21572715 http://dx.doi.org/10.4103/0973-6247.75997 |
_version_ | 1782202318867922944 |
---|---|
author | Al-Joudi, Fawwaz Ali, Anuar Bin Ramli, Majdan Bin Ahmed, Suhair Ismail, Mohd |
author_facet | Al-Joudi, Fawwaz Ali, Anuar Bin Ramli, Majdan Bin Ahmed, Suhair Ismail, Mohd |
author_sort | Al-Joudi, Fawwaz |
collection | PubMed |
description | BACKGROUND: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions. The RBC antigens and their alloantibodies vary among different human populations and ethnic groups, and they do have a clinical significance for their adverse immunological reactions. AIMS: This study aimed at studying the prevalence of RBC alloantibodies at the Blood Transfusion Unit of Hospital Raja Perempuan Zainab II in Kota Bharu, Malaysia. PATIENTS AND METHODS: A cross-sectional study was performed utilizing data obtained in the years 2007 and 2008. Data of antibody screening tests from 5719 patients were examined. RESULTS AND DISCUSSION: The overall prevalence of alloimmunization was 65 (1.13%). The majority of these had a single alloantibody (76.9%), whereas the remaining 23.1% had multiple antibodies. The anti-E antibody comprised the most common alloantibody (24.6%) followed by the anti-Lewis (a) antibodies (18.5%) and the anti-M antibody (13.8%). There were more female recipients than males. CONCLUSIONS: It was concluded that the findings of this work have been comparable with other published works, and that the main factors associated with alloantibody formation were multiple transfusions and pregnancies. The study also emphasizes the necessity for carrying out immunohematology studies prior to every blood transfusion especially in cases that require multiple transfusions for a long period of time such as in thalassemia patients. |
format | Text |
id | pubmed-3082716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-30827162011-05-13 Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan Al-Joudi, Fawwaz Ali, Anuar Bin Ramli, Majdan Bin Ahmed, Suhair Ismail, Mohd Asian J Transfus Sci Original Article BACKGROUND: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions. The RBC antigens and their alloantibodies vary among different human populations and ethnic groups, and they do have a clinical significance for their adverse immunological reactions. AIMS: This study aimed at studying the prevalence of RBC alloantibodies at the Blood Transfusion Unit of Hospital Raja Perempuan Zainab II in Kota Bharu, Malaysia. PATIENTS AND METHODS: A cross-sectional study was performed utilizing data obtained in the years 2007 and 2008. Data of antibody screening tests from 5719 patients were examined. RESULTS AND DISCUSSION: The overall prevalence of alloimmunization was 65 (1.13%). The majority of these had a single alloantibody (76.9%), whereas the remaining 23.1% had multiple antibodies. The anti-E antibody comprised the most common alloantibody (24.6%) followed by the anti-Lewis (a) antibodies (18.5%) and the anti-M antibody (13.8%). There were more female recipients than males. CONCLUSIONS: It was concluded that the findings of this work have been comparable with other published works, and that the main factors associated with alloantibody formation were multiple transfusions and pregnancies. The study also emphasizes the necessity for carrying out immunohematology studies prior to every blood transfusion especially in cases that require multiple transfusions for a long period of time such as in thalassemia patients. Medknow Publications 2011-01 /pmc/articles/PMC3082716/ /pubmed/21572715 http://dx.doi.org/10.4103/0973-6247.75997 Text en © Asian Journal of Transfusion Science http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Al-Joudi, Fawwaz Ali, Anuar Bin Ramli, Majdan Bin Ahmed, Suhair Ismail, Mohd Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan |
title | Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan |
title_full | Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan |
title_fullStr | Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan |
title_full_unstemmed | Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan |
title_short | Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan |
title_sort | prevalence and specificities of red cell alloantibodies among blood recipients in the malaysian state of kelantan |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082716/ https://www.ncbi.nlm.nih.gov/pubmed/21572715 http://dx.doi.org/10.4103/0973-6247.75997 |
work_keys_str_mv | AT aljoudifawwaz prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan AT alianuarbin prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan AT ramlimajdanbin prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan AT ahmedsuhair prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan AT ismailmohd prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan |